Myrexis, Inc. (MYRX) Financial Statements (2026 and earlier)
Company Profile
| Business Address |
305 CHIPETA WAY SALT LAKE CITY, UT 84108 |
| State of Incorp. | DE |
| Fiscal Year End | June 30 |
| Industry (SIC) | 2834 - Pharmaceutical Preparations (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) (USD)Annual | Quarterly
| 6/30/2013 Q4 | 3/31/2013 Q3 | 12/31/2012 Q2 | |||
|---|---|---|---|---|---|
| ASSETS | |||||
| Current Assets | |||||
| Cash, cash equivalents, and short-term investments | 1,514,000 | 81,314,000 | |||
| Cash and cash equivalent | 1,439,000 | 44,380,000 | |||
| Short-term investments | 75,000 | 36,934,000 | |||
| Prepaid expense and other current assets | ✕ | 136,000 | 1,802,000 | ||
| Other undisclosed current assets | |||||
| Total current assets: | 1,650,000 | 83,116,000 | |||
| Noncurrent Assets | |||||
| Property, plant and equipment | 89,000 | ||||
| Long-term investments and receivables | 123,000 | ||||
| Long-term investments | 123,000 | ||||
| Prepaid expense and other noncurrent assets | ✕ | 10,000 | 210,000 | ||
| Total noncurrent assets: | 10,000 | 422,000 | |||
| TOTAL ASSETS: | 1,660,000 | 83,538,000 | |||
| LIABILITIES AND EQUITY | |||||
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 345,000 | 1,307,000 | |||
| Accounts payable | 47,000 | 328,000 | |||
| Accrued liabilities | 298,000 | 979,000 | |||
| Total current liabilities: | 345,000 | 1,307,000 | |||
| Noncurrent Liabilities | |||||
| Total liabilities: | 345,000 | 1,307,000 | |||
| Equity | |||||
| Equity, attributable to parent | 1,315,000 | 82,231,000 | |||
| Common stock | 345,000 | 272,000 | |||
| Additional paid in capital | 129,307,000 | 207,056,000 | |||
| Accumulated other comprehensive income | 1,000 | 2,000 | |||
| Accumulated deficit | (128,338,000) | (125,099,000) | |||
| Total equity: | 1,315,000 | 82,231,000 | |||
| TOTAL LIABILITIES AND EQUITY: | 1,660,000 | 83,538,000 | |||
Income Statement (P&L) (USD)Annual | Quarterly
| 6/30/2013 Q4 | 3/31/2013 Q3 | 12/31/2012 Q2 | ||
|---|---|---|---|---|
| Cost of revenue | ||||
| Operating expenses | (3,291,000) | (4,851,000) | ||
| Other undisclosed operating income | 80,000 | |||
| Operating loss: | (3,211,000) | (4,851,000) | ||
| Other undisclosed income from continuing operations before equity method investments, income taxes | ||||
| Income (loss) from continuing operations before income taxes: | (3,211,000) | (4,851,000) | ||
| Income tax expense | (14,370,000) | |||
| Income (loss) from continuing operations: | (17,581,000) | (4,851,000) | ||
| Income (loss) before gain (loss) on sale of properties: | (17,581,000) | (4,851,000) | ||
| Net income (loss): | (17,581,000) | (4,851,000) | ||
| Other undisclosed net income (loss) attributable to parent | 14,342,000 | 41,000 | ||
| Net loss available to common stockholders, diluted: | (3,239,000) | (4,810,000) | ||
Comprehensive Income (USD)Annual | Quarterly
| 6/30/2013 Q4 | 3/31/2013 Q3 | 12/31/2012 Q2 | ||
|---|---|---|---|---|
| Net income (loss): | (17,581,000) | (4,851,000) | ||
| Comprehensive income (loss): | (17,581,000) | (4,851,000) | ||
| Other undisclosed comprehensive income (loss), net of tax, attributable to parent | 14,343,000 | 39,000 | ||
| Comprehensive loss, net of tax, attributable to parent: | (3,238,000) | (4,812,000) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.